Triple
T5248755
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | AstraZeneca |
E118527
|
entity |
| Predicate | therapeuticArea |
P20980
|
FINISHED |
| Object | rare diseases |
—
|
LITERAL FINISHED |
Named-entity recognition
Before disambiguation, gpt-5-mini classified whether the object phrase is a named entity — the step behind the object's LITERAL type shown above.
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: rare diseases | Statement: [AstraZeneca, therapeuticArea, rare diseases]
Provenance (2 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd4468aacc8190a8196f71855cdf4f |
elicitation | completed |
| NER | batch_69bd7b787b34819081af96de9355bb4f |
ner | completed |
Created at: March 20, 2026, 1:50 p.m.